Patent intelligence · US
US 10485796
LPT-723 and immune checkpoint inhibitor combinations and methods of treatment
LPT-723 and immune checkpoint inhibitor combinations and methods of treatment
Patent details — US 10485796
- Jurisdiction
- US
- Status
- granted
- Grant date
- Nov 26, 2019
- Expiration
- Nov 21, 2039
- Applicant
- Biomed Valley Discoveries, Inc.
- Claims
- 14
- CPC classes
- A61K, A61K2039/507, A61K31/444, A61K39/3955
Quick answer
US 10485796 (LPT-723 and immune checkpoint inhibitor combinations and methods of treatment) is held by Biomed Valley Discoveries, Inc.. Status: granted. Granted Nov 26, 2019. Expires Nov 21, 2039 (13 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Biomed Valley Discoveries, Inc.
- Grant date
- Expiration
- Claims
- 14
- CPC classes
- A61K, A61K2039/507, A61K31/444, A61K39/3955, A61K39/39558, A61K45/06
More from Biomed Valley Discoveries, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12427173
Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-CTLA-4 and/or anti-PD-1 antibodies to treat solid tumor malignancies
granted -
US 12428415
Matriptase 2 inhibitors and uses thereof
granted -
US 12421236
Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor
granted -
US 12420085
Synergistic therapies for inter vertebral disc degeneration
granted -
US 12421231
Azaindole derivatives and their use as ERK kinase inhibitors
granted -
US 12403069
Adapter for use in a planetary mixer
granted -
US 12398179
Nanomolar peptides and derivatives to differentially modulate ephrin receptors
granted -
US 12396924
Adapter for use in a planetary mixer
granted
Frequently asked questions
What is US patent 10485796?
US 10485796 (LPT-723 and immune checkpoint inhibitor combinations and methods of treatment) is held by Biomed Valley Discoveries, Inc.. Status: granted. Granted Nov 26, 2019. Expires Nov 21, 2039 (13 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10485796?
Biomed Valley Discoveries, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 706 pharmaceutical patents for this assignee.
When does US 10485796 expire?
Our index shows an expiration date of Nov 21, 2039 (13 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.